Showing results (131-140 of 165) with videos related to
Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|July 31, 2024
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.Antimicrobial Agents and Chemotherapy|February 9, 2011
Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemiaDavid Andes, Paul G Ambrose, Jeffrey P Hammel, et al.The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 26, 2020
Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient pigletsIgnacio Caballero, Bélinda Ringot-Destrez, Mustapha Si-Tahar, et al.Antimicrobial Agents and Chemotherapy|May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative InfectionsLaura McEntee, Adam Johnson, Nicola Farrington, et al.Antimicrobial Agents and Chemotherapy|August 30, 2017
Pharmacological Basis of CD101 Efficacy: Exposure Shape MattersElizabeth A Lakota, Justin C Bader, Voon Ong, et al.Antimicrobial Agents and Chemotherapy|June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection modelBrian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.Diagnostic Microbiology and Infectious Disease|December 17, 2008
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpointsPaul G Ambrose, Alison K Meagher, Julie A Passarell, et al.Antimicrobial Agents and Chemotherapy|November 25, 2004
Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infectionsScott Van Wart, Luann Phillips, Elizabeth A Ludwig, et al.Antimicrobial Agents and Chemotherapy|April 29, 2020
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 DataElizabeth A Lakota, Scott A Van Wart, Michael Trang, et al.Pageof 17